

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 7.10239997 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.52988837 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.52988837 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.29992356 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.96432841 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.66272968 |
| 7 | negative T cell selection (GO:0043383) | 5.55985513 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.52864128 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.49805790 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.49805790 |
| 11 | T cell migration (GO:0072678) | 4.98103861 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.63404707 |
| 13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.62516717 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.61671826 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.57949369 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.56898409 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48891348 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.48891348 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48891348 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48891348 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48891348 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.48891348 |
| 23 | regulation of RIG-I signaling pathway (GO:0039535) | 4.38151912 |
| 24 | myeloid dendritic cell activation (GO:0001773) | 4.36160058 |
| 25 | myeloid dendritic cell differentiation (GO:0043011) | 4.35888013 |
| 26 | response to interferon-alpha (GO:0035455) | 4.33173834 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.17179048 |
| 28 | negative regulation of viral genome replication (GO:0045071) | 4.07948510 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 4.07924559 |
| 30 | response to peptidoglycan (GO:0032494) | 4.05249297 |
| 31 | thymic T cell selection (GO:0045061) | 4.04773441 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.03762866 |
| 33 | detection of other organism (GO:0098543) | 3.94028770 |
| 34 | response to interferon-beta (GO:0035456) | 3.91635517 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91034640 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.87793744 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87387835 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.85904661 |
| 39 | positive regulation of type 2 immune response (GO:0002830) | 3.85708406 |
| 40 | regulation of necroptotic process (GO:0060544) | 3.85353332 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.84282532 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.82889630 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.81057230 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.81057230 |
| 45 | positive regulation of humoral immune response (GO:0002922) | 3.80222493 |
| 46 | response to type I interferon (GO:0034340) | 3.79901052 |
| 47 | detection of bacterium (GO:0016045) | 3.79006552 |
| 48 | T cell selection (GO:0045058) | 3.78786522 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 3.75168820 |
| 50 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.74343962 |
| 51 | response to interleukin-15 (GO:0070672) | 3.72822005 |
| 52 | lymphocyte migration (GO:0072676) | 3.72665644 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70766685 |
| 54 | neutrophil activation (GO:0042119) | 3.70311193 |
| 55 | natural killer cell mediated immunity (GO:0002228) | 3.70205511 |
| 56 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.70205511 |
| 57 | cellular response to interferon-alpha (GO:0035457) | 3.70017219 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.67570666 |
| 59 | neutrophil activation involved in immune response (GO:0002283) | 3.65337929 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.65255378 |
| 61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64861483 |
| 62 | T-helper cell differentiation (GO:0042093) | 3.63001485 |
| 63 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.63001485 |
| 64 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.61921426 |
| 65 | regulation of response to interferon-gamma (GO:0060330) | 3.60833379 |
| 66 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.60521445 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.58483790 |
| 68 | interferon-gamma production (GO:0032609) | 3.57896585 |
| 69 | positive regulation of isotype switching (GO:0045830) | 3.57494927 |
| 70 | B cell mediated immunity (GO:0019724) | 3.56859709 |
| 71 | necroptotic process (GO:0070266) | 3.52846100 |
| 72 | mature B cell differentiation (GO:0002335) | 3.51632056 |
| 73 | T cell differentiation involved in immune response (GO:0002292) | 3.51431795 |
| 74 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.51431795 |
| 75 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.51431795 |
| 76 | detection of molecule of bacterial origin (GO:0032490) | 3.50698365 |
| 77 | defense response to protozoan (GO:0042832) | 3.50675718 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.50107438 |
| 79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.49911961 |
| 80 | response to muramyl dipeptide (GO:0032495) | 3.49798130 |
| 81 | granulocyte activation (GO:0036230) | 3.49459907 |
| 82 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.48844753 |
| 83 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.48788218 |
| 84 | negative regulation of necroptotic process (GO:0060546) | 3.48184800 |
| 85 | dendritic cell differentiation (GO:0097028) | 3.46983267 |
| 86 | microglial cell activation (GO:0001774) | 3.46543227 |
| 87 | cellular response to interferon-gamma (GO:0071346) | 3.45584301 |
| 88 | detection of external biotic stimulus (GO:0098581) | 3.45244440 |
| 89 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.44693630 |
| 90 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.42392608 |
| 91 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.42151388 |
| 92 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.42151388 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.41022945 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40728763 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.37836524 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37302682 |
| 97 | response to host immune response (GO:0052572) | 3.37302682 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.37206825 |
| 99 | positive regulation of interleukin-2 production (GO:0032743) | 3.36092994 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35681914 |
| 101 | cellular response to interferon-beta (GO:0035458) | 3.33676623 |
| 102 | regulation of hypersensitivity (GO:0002883) | 3.32477982 |
| 103 | positive T cell selection (GO:0043368) | 3.32433134 |
| 104 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.32282494 |
| 105 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.32282494 |
| 106 | positive regulation of B cell differentiation (GO:0045579) | 3.30172009 |
| 107 | response to interferon-gamma (GO:0034341) | 3.28732750 |
| 108 | response to protozoan (GO:0001562) | 3.28368411 |
| 109 | germinal center formation (GO:0002467) | 3.28028999 |
| 110 | regulation of antigen processing and presentation (GO:0002577) | 3.27187642 |
| 111 | myeloid cell activation involved in immune response (GO:0002275) | 3.24034791 |
| 112 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22085592 |
| 113 | regulation of type 2 immune response (GO:0002828) | 3.21129646 |
| 114 | positive regulation of interferon-beta production (GO:0032728) | 3.20783340 |
| 115 | defense response to virus (GO:0051607) | 3.19717532 |
| 116 | natural killer cell activation (GO:0030101) | 3.17524500 |
| 117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.16452308 |
| 118 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15295662 |
| 119 | positive regulation of T cell cytokine production (GO:0002726) | 3.15244426 |
| 120 | T cell activation involved in immune response (GO:0002286) | 3.14592975 |
| 121 | positive regulation of DNA recombination (GO:0045911) | 3.13836243 |
| 122 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.12036687 |
| 123 | T-helper 1 type immune response (GO:0042088) | 3.11693688 |
| 124 | B cell receptor signaling pathway (GO:0050853) | 3.10814000 |
| 125 | leukocyte aggregation (GO:0070486) | 3.10656108 |
| 126 | cellular response to zinc ion (GO:0071294) | 3.09928867 |
| 127 | immunoglobulin mediated immune response (GO:0016064) | 3.09734564 |
| 128 | alpha-beta T cell activation (GO:0046631) | 3.08422321 |
| 129 | sequestering of actin monomers (GO:0042989) | 3.07924703 |
| 130 | T cell costimulation (GO:0031295) | 3.07756235 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07639667 |
| 132 | response to host (GO:0075136) | 3.07639667 |
| 133 | response to host defenses (GO:0052200) | 3.07639667 |
| 134 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.06816421 |
| 135 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05860913 |
| 136 | T cell receptor signaling pathway (GO:0050852) | 3.04583380 |
| 137 | macrophage activation (GO:0042116) | 3.04267466 |
| 138 | lymphocyte chemotaxis (GO:0048247) | 3.04215672 |
| 139 | positive regulation of interleukin-12 production (GO:0032735) | 3.04129137 |
| 140 | positive regulation of interferon-alpha production (GO:0032727) | 3.03576934 |
| 141 | detection of biotic stimulus (GO:0009595) | 3.02722774 |
| 142 | lymphocyte costimulation (GO:0031294) | 3.02268756 |
| 143 | regulation of interleukin-12 production (GO:0032655) | 3.01657753 |
| 144 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.00773876 |
| 145 | positive regulation of B cell mediated immunity (GO:0002714) | 3.00773876 |
| 146 | negative regulation of innate immune response (GO:0045824) | 3.00706879 |
| 147 | regulation of tolerance induction (GO:0002643) | 2.98170205 |
| 148 | interferon-gamma secretion (GO:0072643) | 2.96675197 |
| 149 | cellular response to exogenous dsRNA (GO:0071360) | 2.96160643 |
| 150 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94460711 |
| 151 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.93759344 |
| 152 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.91527306 |
| 153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88992314 |
| 154 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87121820 |
| 155 | positive regulation of tolerance induction (GO:0002645) | 2.85869946 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85463923 |
| 157 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.82947033 |
| 158 | regulation of viral genome replication (GO:0045069) | 2.81853171 |
| 159 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.81848709 |
| 160 | regulation of chronic inflammatory response (GO:0002676) | 2.81583798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.20580165 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.16012349 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.90475646 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.85075438 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.69467974 |
| 6 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.32228783 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.56032459 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42793184 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.34810575 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.25194277 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.17475350 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87879959 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.83988189 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.80427045 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79820733 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.76344054 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64987382 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.58855698 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57884154 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.53898059 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50843205 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.41951951 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41496875 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31774332 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20039712 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.18595200 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17304188 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12568862 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11255608 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10034087 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02264431 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97458414 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94479250 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90683108 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88728641 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87002959 |
| 37 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81341187 |
| 38 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81083352 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79292279 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75313570 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68036673 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66935199 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65629465 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62386337 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.61990646 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53837960 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52117541 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51631787 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47615520 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46205855 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42029544 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41631971 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38256256 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38043005 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36641620 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34249954 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25810285 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24603665 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24320720 |
| 60 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23102126 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22081347 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21042164 |
| 63 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19903691 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18244345 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15797521 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15675618 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13169209 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12591619 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07748740 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07271910 |
| 71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06559632 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05418593 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04211886 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99154029 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99107402 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98827746 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96427682 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96294360 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96112154 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94870860 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93127352 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91400466 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90662680 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90063444 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89579036 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89254615 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86211222 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85360639 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84024998 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83995362 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83171185 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83047149 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82049022 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81574740 |
| 95 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.80938188 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79742336 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79516787 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78625215 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77453659 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77319723 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74024221 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71579252 |
| 103 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71074843 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.70232878 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70114913 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69451494 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.68701492 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.68568918 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67035779 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66805081 |
| 111 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66362830 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.66289092 |
| 113 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.65836338 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64334048 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.61795663 |
| 116 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.59907803 |
| 117 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.59383629 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58523216 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.58486375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.70844312 |
| 2 | MP0000685_abnormal_immune_system | 4.03128686 |
| 3 | MP0005671_abnormal_response_to | 3.81370210 |
| 4 | MP0002166_altered_tumor_susceptibility | 3.67659119 |
| 5 | MP0009785_altered_susceptibility_to | 3.28880552 |
| 6 | MP0001790_abnormal_immune_system | 3.24959769 |
| 7 | MP0005387_immune_system_phenotype | 3.24959769 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.24445364 |
| 9 | MP0003763_abnormal_thymus_physiology | 3.09451300 |
| 10 | MP0001800_abnormal_humoral_immune | 3.08395920 |
| 11 | MP0002006_tumorigenesis | 3.03511204 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.96638144 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.93319520 |
| 14 | MP0003436_decreased_susceptibility_to | 2.86910157 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.76823081 |
| 16 | MP0004510_myositis | 2.75698403 |
| 17 | MP0002723_abnormal_immune_serum | 2.75375138 |
| 18 | MP0002009_preneoplasia | 2.75253304 |
| 19 | MP0001819_abnormal_immune_cell | 2.68085089 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.67937592 |
| 21 | MP0005025_abnormal_response_to | 2.63407404 |
| 22 | MP0002254_reproductive_system_inflammat | 2.51388458 |
| 23 | MP0002419_abnormal_innate_immunity | 2.37859778 |
| 24 | MP0001873_stomach_inflammation | 2.35467699 |
| 25 | MP0002398_abnormal_bone_marrow | 2.34995451 |
| 26 | MP0000716_abnormal_immune_system | 2.22150140 |
| 27 | MP0006082_CNS_inflammation | 2.14716211 |
| 28 | MP0002405_respiratory_system_inflammati | 2.09148770 |
| 29 | MP0005310_abnormal_salivary_gland | 1.98807605 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.97288365 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.96547654 |
| 32 | MP0001348_abnormal_lacrimal_gland | 1.95760689 |
| 33 | MP0004947_skin_inflammation | 1.84658710 |
| 34 | MP0003724_increased_susceptibility_to | 1.84019820 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.83447868 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.82030006 |
| 37 | MP0002429_abnormal_blood_cell | 1.80730330 |
| 38 | MP0002722_abnormal_immune_system | 1.80068339 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.69227397 |
| 40 | MP0002163_abnormal_gland_morphology | 1.63825171 |
| 41 | MP0001853_heart_inflammation | 1.63822167 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.63687687 |
| 43 | MP0005451_abnormal_body_composition | 1.62054910 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.61868778 |
| 45 | MP0008260_abnormal_autophagy | 1.51635985 |
| 46 | MP0003448_altered_tumor_morphology | 1.40980620 |
| 47 | MP0003075_altered_response_to | 1.39305920 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.39281015 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.38666209 |
| 50 | MP0008004_abnormal_stomach_pH | 1.37578910 |
| 51 | MP0008469_abnormal_protein_level | 1.34944317 |
| 52 | MP0000858_altered_metastatic_potential | 1.34441510 |
| 53 | MP0003303_peritoneal_inflammation | 1.31084099 |
| 54 | MP0003866_abnormal_defecation | 1.29800442 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.29129418 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.27891392 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.25721961 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.25721961 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.24476926 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.23829304 |
| 61 | MP0002933_joint_inflammation | 1.23634931 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.20972647 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.20514830 |
| 64 | MP0003690_abnormal_glial_cell | 1.11287018 |
| 65 | MP0004883_abnormal_blood_vessel | 1.05345571 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.04885647 |
| 67 | MP0009764_decreased_sensitivity_to | 1.02648117 |
| 68 | MP0005164_abnormal_response_to | 1.01340407 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.00928874 |
| 70 | MP0002019_abnormal_tumor_incidence | 0.92160198 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.92060509 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.91009882 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.90467863 |
| 74 | MP0006054_spinal_hemorrhage | 0.90247186 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.90177768 |
| 76 | MP0000490_abnormal_crypts_of | 0.87617668 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 0.84617681 |
| 78 | MP0009840_abnormal_foam_cell | 0.84374102 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.84035016 |
| 80 | MP0001346_abnormal_lacrimal_gland | 0.79429467 |
| 81 | MP0005390_skeleton_phenotype | 0.79103782 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.78402084 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.77452443 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.77131040 |
| 85 | MP0010307_abnormal_tumor_latency | 0.76916556 |
| 86 | MP0003828_pulmonary_edema | 0.76543881 |
| 87 | MP0008057_abnormal_DNA_replication | 0.75539643 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.71670283 |
| 89 | MP0003195_calcinosis | 0.70383733 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.70082629 |
| 91 | MP0009278_abnormal_bone_marrow | 0.69489497 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.69397792 |
| 93 | MP0003045_fibrosis | 0.69161254 |
| 94 | MP0009763_increased_sensitivity_to | 0.68509048 |
| 95 | MP0003091_abnormal_cell_migration | 0.68166469 |
| 96 | MP0000371_diluted_coat_color | 0.67671375 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.66568497 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.66344955 |
| 99 | MP0008874_decreased_physiological_sensi | 0.64245778 |
| 100 | MP0008007_abnormal_cellular_replicative | 0.62575430 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.62319955 |
| 102 | MP0000604_amyloidosis | 0.59398094 |
| 103 | MP0000249_abnormal_blood_vessel | 0.59295433 |
| 104 | MP0001851_eye_inflammation | 0.58866115 |
| 105 | MP0003795_abnormal_bone_structure | 0.58368755 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.56080252 |
| 107 | MP0002132_abnormal_respiratory_system | 0.54858778 |
| 108 | MP0001881_abnormal_mammary_gland | 0.54457130 |
| 109 | MP0005023_abnormal_wound_healing | 0.54155093 |
| 110 | MP0001243_abnormal_dermal_layer | 0.54148060 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.53166899 |
| 112 | MP0001663_abnormal_digestive_system | 0.52508695 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.50923935 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.50429948 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.49421872 |
| 116 | MP0000313_abnormal_cell_death | 0.48450832 |
| 117 | MP0005165_increased_susceptibility_to | 0.48436463 |
| 118 | MP0005535_abnormal_body_temperature | 0.48397226 |
| 119 | MP0000343_altered_response_to | 0.47674661 |
| 120 | MP0000609_abnormal_liver_physiology | 0.45811482 |
| 121 | MP0005166_decreased_susceptibility_to | 0.45115494 |
| 122 | MP0004381_abnormal_hair_follicle | 0.43155665 |
| 123 | MP0001191_abnormal_skin_condition | 0.42242993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 5.12722922 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.09884467 |
| 3 | Myositis (HP:0100614) | 5.09693852 |
| 4 | Recurrent viral infections (HP:0004429) | 4.96809991 |
| 5 | Chronic otitis media (HP:0000389) | 4.96043634 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.86987565 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.82863703 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.82672402 |
| 9 | T lymphocytopenia (HP:0005403) | 4.82670050 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.69963596 |
| 11 | Nasal polyposis (HP:0100582) | 4.43167014 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.30040016 |
| 13 | Optic neuritis (HP:0100653) | 4.30040016 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.26170335 |
| 15 | Recurrent bronchitis (HP:0002837) | 4.13295545 |
| 16 | Orchitis (HP:0100796) | 4.06292377 |
| 17 | Thrombocytosis (HP:0001894) | 4.02747756 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.98768398 |
| 19 | Increased IgM level (HP:0003496) | 3.97903112 |
| 20 | Abnormality of T cells (HP:0002843) | 3.96283719 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.85496815 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.81462959 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.73987300 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.73987300 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.71590201 |
| 26 | Recurrent skin infections (HP:0001581) | 3.62597495 |
| 27 | Eosinophilia (HP:0001880) | 3.56744112 |
| 28 | Vasculitis (HP:0002633) | 3.54428465 |
| 29 | Severe combined immunodeficiency (HP:0004430) | 3.50435646 |
| 30 | Leukocytosis (HP:0001974) | 3.43389444 |
| 31 | Fatigue (HP:0012378) | 3.43038344 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.40894580 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.39791413 |
| 34 | Thyroiditis (HP:0100646) | 3.39245413 |
| 35 | Combined immunodeficiency (HP:0005387) | 3.36448783 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 3.36108047 |
| 37 | Pulmonary infiltrates (HP:0002113) | 3.33898739 |
| 38 | Meningitis (HP:0001287) | 3.31822374 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.31659651 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 3.29812387 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.27130849 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.27130849 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 3.27130849 |
| 44 | Arterial thrombosis (HP:0004420) | 3.24367208 |
| 45 | Granulocytopenia (HP:0001913) | 3.20158752 |
| 46 | Hypergammaglobulinemia (HP:0010702) | 3.20085339 |
| 47 | Increased IgE level (HP:0003212) | 3.19251041 |
| 48 | Inflammation of the large intestine (HP:0002037) | 3.16281534 |
| 49 | Abnormality of macrophages (HP:0004311) | 3.14868132 |
| 50 | IgG deficiency (HP:0004315) | 3.13133473 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 3.10441531 |
| 52 | Abnormality of the fingertips (HP:0001211) | 3.08217428 |
| 53 | Encephalitis (HP:0002383) | 3.07833918 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 3.02580075 |
| 55 | Colitis (HP:0002583) | 2.98916805 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98047850 |
| 57 | IgM deficiency (HP:0002850) | 2.95840351 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.88358947 |
| 59 | Loss of speech (HP:0002371) | 2.87025895 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.85446102 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84506342 |
| 62 | Urticaria (HP:0001025) | 2.84347615 |
| 63 | Chronic diarrhea (HP:0002028) | 2.84083835 |
| 64 | Gangrene (HP:0100758) | 2.82964113 |
| 65 | Pustule (HP:0200039) | 2.79532294 |
| 66 | Obstructive lung disease (HP:0006536) | 2.78649593 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78649593 |
| 68 | Malnutrition (HP:0004395) | 2.77559546 |
| 69 | Lymphopenia (HP:0001888) | 2.76481535 |
| 70 | Periodontitis (HP:0000704) | 2.75753418 |
| 71 | Hemoptysis (HP:0002105) | 2.72697811 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.70491474 |
| 73 | B lymphocytopenia (HP:0010976) | 2.67257638 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.67257638 |
| 75 | Joint swelling (HP:0001386) | 2.66810263 |
| 76 | Chronic sinusitis (HP:0011109) | 2.65610079 |
| 77 | Anorexia (HP:0002039) | 2.52288886 |
| 78 | Stomatitis (HP:0010280) | 2.51796344 |
| 79 | Gingival bleeding (HP:0000225) | 2.51263158 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.48598739 |
| 81 | Cellulitis (HP:0100658) | 2.47241718 |
| 82 | Gingivitis (HP:0000230) | 2.45620804 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43922623 |
| 84 | Chest pain (HP:0100749) | 2.39719151 |
| 85 | Hematochezia (HP:0002573) | 2.38671681 |
| 86 | Amyloidosis (HP:0011034) | 2.37916216 |
| 87 | Peritonitis (HP:0002586) | 2.33383209 |
| 88 | Amaurosis fugax (HP:0100576) | 2.33379218 |
| 89 | Bronchitis (HP:0012387) | 2.32609663 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.32292853 |
| 91 | Polyneuropathy (HP:0001271) | 2.31741534 |
| 92 | Episodic fever (HP:0001954) | 2.31555853 |
| 93 | Epistaxis (HP:0000421) | 2.30724123 |
| 94 | Disinhibition (HP:0000734) | 2.30550846 |
| 95 | Dysostosis multiplex (HP:0000943) | 2.24177192 |
| 96 | Purpura (HP:0000979) | 2.23171462 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.21231740 |
| 98 | Petechiae (HP:0000967) | 2.19958036 |
| 99 | Abnormality of the pericardium (HP:0001697) | 2.19268430 |
| 100 | Acute myeloid leukemia (HP:0004808) | 2.19124687 |
| 101 | Increased serum ferritin (HP:0003281) | 2.17373477 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.16363108 |
| 103 | Polycythemia (HP:0001901) | 2.14336833 |
| 104 | Recurrent sinusitis (HP:0011108) | 2.13617369 |
| 105 | Glomerulopathy (HP:0100820) | 2.13439723 |
| 106 | Premature loss of primary teeth (HP:0006323) | 2.12822371 |
| 107 | IgA deficiency (HP:0002720) | 2.10337024 |
| 108 | Abnormality of the endocardium (HP:0004306) | 2.10212610 |
| 109 | Lymphoma (HP:0002665) | 2.10127331 |
| 110 | Myocardial infarction (HP:0001658) | 2.09671127 |
| 111 | Hypoplasia of the thymus (HP:0000778) | 2.07875012 |
| 112 | Vertigo (HP:0002321) | 2.07773353 |
| 113 | Skin rash (HP:0000988) | 2.06235611 |
| 114 | Arthralgia (HP:0002829) | 2.05411310 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.03816115 |
| 116 | Verrucae (HP:0200043) | 2.01016785 |
| 117 | Papilloma (HP:0012740) | 2.01016785 |
| 118 | Pulmonary embolism (HP:0002204) | 2.00806199 |
| 119 | Emphysema (HP:0002097) | 2.00312354 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 1.99670143 |
| 121 | Thrombophlebitis (HP:0004418) | 1.98975590 |
| 122 | Abnormality of the peritoneum (HP:0002585) | 1.98823767 |
| 123 | Recurrent pneumonia (HP:0006532) | 1.98004373 |
| 124 | Skin ulcer (HP:0200042) | 1.96563327 |
| 125 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95363995 |
| 126 | Gastrointestinal stroma tumor (HP:0100723) | 1.94935212 |
| 127 | Vacuolated lymphocytes (HP:0001922) | 1.94089148 |
| 128 | Exertional dyspnea (HP:0002875) | 1.91338785 |
| 129 | Osteomyelitis (HP:0002754) | 1.90808224 |
| 130 | Prolonged bleeding time (HP:0003010) | 1.87890194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.70923302 |
| 2 | TYK2 | 3.76690876 |
| 3 | MAP4K1 | 3.70806215 |
| 4 | JAK3 | 3.63009356 |
| 5 | TXK | 3.27414759 |
| 6 | MAP3K13 | 3.19513714 |
| 7 | TBK1 | 3.14012465 |
| 8 | IKBKE | 3.11489498 |
| 9 | IKBKB | 2.88287349 |
| 10 | IRAK4 | 2.66562950 |
| 11 | JAK1 | 2.65542241 |
| 12 | KIT | 2.46648396 |
| 13 | ZAP70 | 2.31221408 |
| 14 | FLT3 | 2.12911578 |
| 15 | ERN1 | 2.12010429 |
| 16 | CHUK | 1.98375111 |
| 17 | FGFR4 | 1.96778329 |
| 18 | MATK | 1.90494715 |
| 19 | PRPF4B | 1.90475022 |
| 20 | ITK | 1.89626863 |
| 21 | BLK | 1.85093442 |
| 22 | NLK | 1.80716532 |
| 23 | GRK7 | 1.78501270 |
| 24 | TEC | 1.73925360 |
| 25 | GRK6 | 1.69767507 |
| 26 | SYK | 1.68153675 |
| 27 | BTK | 1.66817196 |
| 28 | CSF1R | 1.65408240 |
| 29 | LCK | 1.53477062 |
| 30 | NME2 | 1.52811806 |
| 31 | FGFR3 | 1.51204310 |
| 32 | CSK | 1.48931449 |
| 33 | RIPK1 | 1.44855879 |
| 34 | STK10 | 1.39848170 |
| 35 | TAOK2 | 1.37315520 |
| 36 | EPHB1 | 1.35553199 |
| 37 | MAP3K3 | 1.35099309 |
| 38 | MAP3K11 | 1.31358114 |
| 39 | MST4 | 1.26775213 |
| 40 | TAOK3 | 1.24409857 |
| 41 | TAOK1 | 1.19806670 |
| 42 | RIPK4 | 1.14933500 |
| 43 | PIM1 | 1.12122913 |
| 44 | HCK | 1.07896348 |
| 45 | MAP3K1 | 1.03603999 |
| 46 | RPS6KA4 | 1.01636643 |
| 47 | JAK2 | 1.00850068 |
| 48 | NEK9 | 0.99031235 |
| 49 | EPHA3 | 0.98459972 |
| 50 | CDC42BPA | 0.98129781 |
| 51 | MAP3K10 | 0.97063100 |
| 52 | PRKAA2 | 0.95706225 |
| 53 | ACVR1B | 0.94102812 |
| 54 | LRRK2 | 0.93430004 |
| 55 | PIM2 | 0.89189193 |
| 56 | LYN | 0.84981616 |
| 57 | IRAK1 | 0.81362332 |
| 58 | IRAK3 | 0.79859342 |
| 59 | PRKCQ | 0.77322393 |
| 60 | SIK2 | 0.77089056 |
| 61 | PIK3CG | 0.75099577 |
| 62 | SIK3 | 0.73865666 |
| 63 | TGFBR1 | 0.73584823 |
| 64 | CLK1 | 0.71264349 |
| 65 | PKN1 | 0.71240270 |
| 66 | BMPR2 | 0.68308266 |
| 67 | STK4 | 0.68164676 |
| 68 | MAP3K5 | 0.67087754 |
| 69 | MAP2K6 | 0.65196369 |
| 70 | DDR2 | 0.64212253 |
| 71 | KDR | 0.63374105 |
| 72 | PDK1 | 0.63251454 |
| 73 | TGFBR2 | 0.61893509 |
| 74 | FES | 0.59859529 |
| 75 | MAPKAPK2 | 0.58896367 |
| 76 | MAP2K3 | 0.55212345 |
| 77 | TLK1 | 0.55066969 |
| 78 | PTK6 | 0.54834660 |
| 79 | HIPK2 | 0.52921470 |
| 80 | MELK | 0.50520592 |
| 81 | TESK2 | 0.47329186 |
| 82 | NUAK1 | 0.46702974 |
| 83 | MAPK7 | 0.46225647 |
| 84 | PDPK1 | 0.46216385 |
| 85 | CDK9 | 0.45926967 |
| 86 | PRKCD | 0.45321145 |
| 87 | ADRBK2 | 0.43255762 |
| 88 | EIF2AK2 | 0.42769333 |
| 89 | KSR2 | 0.42323320 |
| 90 | RAF1 | 0.42251309 |
| 91 | MAP3K12 | 0.41345341 |
| 92 | TRPM7 | 0.40522233 |
| 93 | ABL1 | 0.40330615 |
| 94 | EEF2K | 0.39940952 |
| 95 | ARAF | 0.38399890 |
| 96 | MOS | 0.38218285 |
| 97 | MAP3K7 | 0.38029943 |
| 98 | RPS6KA5 | 0.37674449 |
| 99 | STK24 | 0.37105918 |
| 100 | CDK4 | 0.32761549 |
| 101 | RPS6KA6 | 0.31275113 |
| 102 | FGR | 0.31098264 |
| 103 | YES1 | 0.30447077 |
| 104 | TNK2 | 0.29141396 |
| 105 | MAPK11 | 0.29029563 |
| 106 | RET | 0.28595896 |
| 107 | MARK2 | 0.28237528 |
| 108 | MARK3 | 0.26687302 |
| 109 | PTK2B | 0.26017327 |
| 110 | BMX | 0.25683644 |
| 111 | NEK2 | 0.24381492 |
| 112 | RPS6KA1 | 0.23720438 |
| 113 | MAP3K6 | 0.22691891 |
| 114 | EGFR | 0.22666536 |
| 115 | IRAK2 | 0.22595804 |
| 116 | SMG1 | 0.22164936 |
| 117 | PRKD2 | 0.21867893 |
| 118 | TTN | 0.21603820 |
| 119 | MAP3K8 | 0.19842201 |
| 120 | DYRK1B | 0.19409119 |
| 121 | MAPK3 | 0.18985458 |
| 122 | CDK6 | 0.18807840 |
| 123 | PKN2 | 0.18596006 |
| 124 | INSR | 0.18156338 |
| 125 | BMPR1B | 0.17562760 |
| 126 | MAPK4 | 0.17540850 |
| 127 | KSR1 | 0.16985443 |
| 128 | IGF1R | 0.16544699 |
| 129 | AKT1 | 0.16533172 |
| 130 | FYN | 0.16185910 |
| 131 | BRAF | 0.13164725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.64332068 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.62333111 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.26634602 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.26573549 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.97872918 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.91778332 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80156597 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.72384882 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38481331 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37300641 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.34219419 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.22886837 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18468275 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18099115 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.16778389 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01026073 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97937589 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.95526950 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89667933 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.89194041 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82344643 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79613542 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.69989579 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.66554770 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63524650 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62970275 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61369055 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53693982 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.42930891 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38911597 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.37972061 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33144119 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.31061520 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30960631 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.28841628 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23058421 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.22792837 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.19507164 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19428761 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11230895 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.08041312 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01904339 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.00615004 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.00410815 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97899756 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93031726 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92989490 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88474671 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88422116 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87573544 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85382951 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85099758 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84600606 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.81862623 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80554910 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77248093 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76210667 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75041772 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73949328 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.72543397 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69415414 |
| 62 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68794335 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68518650 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65839110 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53636655 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52432205 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52228961 |
| 68 | Proteasome_Homo sapiens_hsa03050 | 0.50250352 |
| 69 | DNA replication_Homo sapiens_hsa03030 | 0.50205608 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49327668 |
| 71 | Base excision repair_Homo sapiens_hsa03410 | 0.46192513 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42879832 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41914780 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40045502 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38072500 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.37855410 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36920373 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31578001 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31427131 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30324089 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30230181 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29862362 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29159949 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28745092 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28452342 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28011974 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27887486 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27749863 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27611287 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27410734 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27081781 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.26969331 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.26755539 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.26511729 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25162152 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24832553 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23914080 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.23754482 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23717664 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23686158 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.20718370 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20236882 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18855504 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17325068 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15950886 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15716373 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14051073 |
| 108 | Mismatch repair_Homo sapiens_hsa03430 | 0.13509998 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.12888513 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.12823093 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.11755846 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.10373546 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10338700 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.09086440 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.08979663 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.08608246 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08282938 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07773360 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07567968 |

